In contrast, neoplastic basophils from chronic myeloid leukemia (CML) patients were TRAIL sensitive, despite lower expression of DR5 [107]. This evidence concerns the gene TNFSF10 and chronic myelogenous leukemia, BCR-ABL1 positive.